New data from Noom suggests that people who put more effort into eating healthy and working out see the best results from weight-loss drugs.
Digital healthcare platform Noom is launching oral weight loss medication, beginning with FDA-approved Metformin.
As GLP-1 drugs surge, here's how telehealth companies and brick-and-mortar fitness giants are responding to the Ozempic era.
Zumba instructors can gain an edge by becoming Noom Mindset Coaches as the dance-fitness brand continues to expand its reach.
A new market has emerged which focuses on maintaining the lean muscle mass of consumers taking weight-loss drugs like Ozempic.
Noom co-founder Saeju Jeong will continue as the wellness company's executive chairman of the board after serving as CEO for 16 years.
Sign Up to Our Newsletter
